The Optimal MMF Dose in Tacrolimus Treated Patients


Autoria(s): van Gelder, T.; Bouamar, R.; Shuker, N.; Hesselink, D.; Weimar, W.; Kaplan, B.; Bernasconi, Corrado Angelo
Data(s)

17/03/2014

Formato

application/pdf

Identificador

http://boris.unibe.ch/58328/1/vanGelder2014_AmJTranspl.pdf

van Gelder, T.; Bouamar, R.; Shuker, N.; Hesselink, D.; Weimar, W.; Kaplan, B.; Bernasconi, Corrado Angelo (2014). The Optimal MMF Dose in Tacrolimus Treated Patients. American journal of transplantation, 14(5), p. 1221. Wiley-Blackwell 10.1111/ajt.12682 <http://dx.doi.org/10.1111/ajt.12682>

doi:10.7892/boris.58328

info:doi:10.1111/ajt.12682

urn:issn:1600-6135

Idioma(s)

eng

Publicador

Wiley-Blackwell

Relação

http://boris.unibe.ch/58328/

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

van Gelder, T.; Bouamar, R.; Shuker, N.; Hesselink, D.; Weimar, W.; Kaplan, B.; Bernasconi, Corrado Angelo (2014). The Optimal MMF Dose in Tacrolimus Treated Patients. American journal of transplantation, 14(5), p. 1221. Wiley-Blackwell 10.1111/ajt.12682 <http://dx.doi.org/10.1111/ajt.12682>

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

PeerReviewed